Suppression of the p300-dependent MDM2 negative-feedback loop induces the p53 apoptotic function

Genes and Development

Volumn 12, Issue 13, 1998, Pages 1975-1985

  Thomas, Anju ^a   White, Eileen ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Apoptosis; Bcl 2; E1A; E1B 19K; Mdm2; p300; p53; Transcription

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53; TRANSCRIPTION FACTOR; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; NEGATIVE FEEDBACK; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0032127947     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.13.1975     Document Type: Article

References (69)

1. Abraham, S.E., S. Lobo, P. Yaciuk, H.G. Wang, and E. Moran. 1993. p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. Oncogene 8: 1639-1647.
2. Arany, Z., W. Sellers, D. Livingston, and R. Eckner. 1994. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77: 799-800.
3. Avantaggiati, M.L., V. Ogryzko, K. Gardner, A. Giordano, A.S. Levine, and K. Kelly. 1997. Recruitment of p300-CBP in p53-dependent signal pathways. Cell 89: 1175-1184.
4. Bannister, A.J. and T. Kouzarides. 1995. CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J. 14: 4758-4762.
5. _. 1996. The CBP coactivator is a histone acetyltransferase. Nature 384: 641-643.
6. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO J. 12: 461-468.
7. Buckbinder, L., R. Talbott, S. Velasco-Miguel, I. Takenaka, B. Faha, B.R. Seizinger, and N. Kley. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377: 646-649.
8. Chen, J., X. Wu, J. Lin, and A.J. Levine. 1996a. mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol. Cell. Biol. 16: 2445-2452.
9. Chen, X., L.J. Ko, L. Jayaraman, and C. Prives. 1996b. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes & Dev. 10: 2438-2451.
10. Chiou, S.-K. and E. White. 1997. p300 binding by E1A cosegregates with p53 induction but is dispensable for apoptosis. J. Virol. 71: 3515-3525.
11. Chiou, S.-K., L. Rao, and E. White. 1994a. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14: 2556-2563.
12. Chiou, S.-K., C.C. Tseng, L. Rao, and E. White. 1994b. Functional complementation of the adenovirus E1B 19K protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68: 6553-6566.
13. Chrivia, J.C., R.P. Kwok, N. Lamb, M. Hagiwara, M.R. Montminy, and R.H. Goodman. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365: 855-859.
14. Dai, P., H. Akimaru, Y. Tanaka, D.X. Hou, T. Yasukawa, C. Kanei-Ishii, T. Takahashi, and S. Ishii. 1996. CBP as a transcriptional coactivator of c-Myb. Genes & Dev. 10: 528-540.
15. Debbas, M. and E. White. 1993. Wild-type p53 mediates apoptosis by E1A which is inhibited by E1B. Genes &. Dev. 7: 546-554.
16. Donehower, L.A., M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery, J.S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215-221.
17. Dyson, N. and E. Harlow. 1992. Adenovirus E1A targets key regulators of cell proliferation. Cancer Surv. 12: 161-195.
18. Eckner, R., M.E. Ewen, D. Newsome, M. Gerdes, J.A. DeCaprio, J.B. Lawrence, and D.M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcription adaptor. Genes & Dev. 8: 869-884.
19. El-Deiry, W.S., S.E. Kern, J.A. Pietenpol, K.W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nature Genet. 1: 45-49.
20. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
21. Fakharzadeh, S.S., S.P. Trusko, and D.L. George. 1991. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10: 1565-1569.
22. Funk, W.D., D.T. Pak, R.H. Karas, W.E. Wright, and J.W. Shay. 1992. A transcriptionally active DNA-binding site for human p53 protein complexes. Mol. Cell. Biol 12: 2866-2871.
23. Gu, W. and R.G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606.
24. Gu, W., X.-L. Shi, and R.G. Roeder. 1997. Synergistic activation of transcription by CBP and p53. Nature 387: 819-823.
25. Han, J., P. Sabbatini, D. Perez, L. Rao, D. Modha, and E. White. 1996. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes & Dev. 10: 461-477.
26. Haupt, Y., Y. Barak, and M. Oren. 1996. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J. 15: 1596-1606.
27. Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
28. Hollstein, M., D. Sidransky, B. Vogelstein, and C. Harris. 1991. p53 mutations in human cancers. Science 253: 49-53.
29. Kastan, M.B., Q. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett, B. Vogelstein, and A.J. Fornace. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 13: 587-597.
30. Ko, L.J. and C. Prives. 1996. p53: Puzzle and paradigm. Genes & Dev. 10: 1054-1072.
31. Kubbutat, M.H.G., S.N. Jones, and K.H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387: 299-303.
32. Kwok, R.P., J.R. Lundblad, J.C. Chrivia, J.P. Richards, H.P. Bachinger, R.G. Brennan, S.G. Roberts, M.R. Green, and R.H. Goodman. 1994. Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370: 223-226.
33. Lee, J.S., K.M. Galvin, R.H. See, R. Eckner, D. Livingston, E. Moran, and Y. Shi. 1995. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes & Dev. 9: 1188-1198.
34. Levine, A.J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
35. Lill, N.L., S.R. Grossman, D. Ginsberg, J. DeCaprio, and D.M. Livingston. 1997. Binding and modulation of p53 by p300/ CBP coactivators. Nature 387: 823-827.
36. Lowe, S. and H.E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus-5 E1A and accompanies apoptosis. Genes & Dev. 7: 535-545.
37. Miyashita, T. and J.C. Reed. 1995. Tumor suppressor P53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
38. Momand, J., G.P. Zambetti, D.C. Olson, D. George, and A.J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
39. Montes de Oca Luna, R., D.S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206.
40. Moran, E. 1993. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3: 63-70.
41. Muraoka, M., M. Konishi, R. Yanoshita, K. Tanaka, N. Shitara, J.M. Chong, T. Iwama, and M. Miyaki. 1996. p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12: 1565-1569.
42. Murphy, M., A. Hinman, and A.J. Levine. 1996. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes & Dev. 10: 2971-2980.
43. Ogryzko, V.V., R.L. Schiltz, V. Russanova, B.H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959.
44. Okamoto, K. and D. Beach. 1994. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13: 4816-4822.
45. Oliner, J.D., J. Pietenpol, S. Thiagalingam, J. Gyuris, K.W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53. Nature 362: 857-860.
46. Pietenpol, J.A., T. Tokino, S. Thiagalingam, W.S. El-Deiry, K.W. Kinzler, and B. Vogelstein. 1994. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. 91: 1998-2002.
47. Querido, E.J., J.G. Teodoro, and P.E. Branton. 1997. Accumulation of p53 induced by the adenovirus E1A protein requires regions involved in the stimulation of DNA synthesis. J. Virol. 71: 3526-3533.
48. Rao, L. and E. White. 1997. Bcl-2 and ICE family of apoptotic regulators: Making a connection. Curr. Opin. Genet. Dev. 7: 52-58.
49. Rao, L., D. Perez, and E. White. 1996. Lamin proteolysis facilitates nuclear events during apoptosis. J. Cell. Biol. 135: 1441-1455.
50. Sabbatini, P., S.-K. Chiou, L. Rao, and E. White. 1995a. Modulation of p53-mediated transcription and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol. 15: 1060-1070.
51. Sabbatini, P., J. Lin, A.J. Levine, and E. White. 1995b. Essential role for p53-mediated transcription in apoptosis but not growth suppression. Genes &. Dev. 9: 2184-2192.
52. Sabbatini, P., J.H. Han, S.-K. Chiou, D. Nicholson, and E. White. 1997. Interleukin 1β converting enzyme-like proteases are essential for p53-mediated transcriptionally dependent apoptosis. Cell Growth Differ. 8: 643-653.
53. Sakamuro, D., V. Eviner, K.J. Elliot, L. Showe, E. White, and G.C. Prendergast. 1995. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms. Oncogene 11: 2411-2418.
54. Sanchez-Prieto, R., M. Lleonart, and S. Cajal. 1995. Lack of correlation between p53 protein level and sensitivity to DNA-damaging agents in keratinocytes carrying adenovirus E1A mutants. Oncogene 11: 675-682.
55. Scolnick, D.M., N.H. Chehab, E.S. Stavridi, M.C. Lien, L. Caruso, E. Moran, S.L. Berger, and T.D. Halazonetis. 1997. CREB-binding protein and p300-CBP-associated factor are transcriptional coactivators of the p53-tumor suppressor protein. Cancer Res. 57: 3693-3696.
56. Shen, Y. and T. Shenk. 1994. Relief of p53 mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc. Natl. Acad. Sci. 91: 8940-8944.
57. Steegenga, W.T., T. van Laar, N. Riteco, A. Mandarino, A. Shvarts, A.J. van der Eb, and A.G. Jochemsen. 1996. Adenovirus E1A proteins inhibit activation of transcription by p53. Mol. Cell Biol. 16: 2101-2109.
58. Stein, R.W., M. Corrigan, P. Yaciuk, J. Whelan, and E. Moran. 1991. Analysis of E1A-mediated growth regulation functions: Binding of the 300-kilodalton cellular product correlates with E1A repression function and DNA synthesis-inducing activity. J. Virol. 64: 4421-4427.
59. II60. Science 267: 100-104.
60. Vogelstein, B. and K.W. Kinzler. 1992. p53 Function and dysfunction. Cell 70: 523-526.
61. Wang, H.-G.H., Y. Rikitake, M.C. Carter, P. Yaciuk, S.E. Abraham, B. Zerler, and E. Moran. 1992. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and the control of cell growth. J. Virol. 67: 476-488.
62. White, E. 1993. Regulation of apoptosis by the transforming genes of the DNA tumor virus adenovirus. Proc. Soc. Exp. Biol. Med. 204: 30-39.
63. _. 1996. Life, death, and the pursuit of apoptosis. Genes &. Dev. 10: 1-15.
64. White, E. and L.R. Gooding 1994. Regulation of apoptosis by human adenoviruses. In Apoptosis: The molecular basis for cell death II. (ed. Tomei, L.D. and F.O. Cope), pp. 111-141. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
65. White, E., R. Cipriani, P. Sabbatini, and A. Denton. 1991. The adenovirus E1B 19-Kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 65: 2968-2978.
66. Whyte, P., K. Buchkovich, J.M. Horowitz, S.H. Friend, M. Raybuck, R.A. Weinbert, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334: 124-129.
67. Wu, X., J.H. Bayle, D. Olson, and A.J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes &. Dev. 7: 1126-1132.
68. Yang, X.J., V.V. Ogryzko, J. Nishikawa, B.H. Howard, and Y.A. Nakatani. 1996. p300/CBP-associated factor that competes with the adenoviral oncoprotein E1a. Nature 382: 319-324.
69. Yoshida, K., L. Venkatesh, M. Kuppuswamy, and G. Chinnadurai. 1987. Adenovirus transforming 19-kD T antigen has an enhancer dependent trans-activation function and relieves enchancer repression mediated by viral and cellular genes. Genes & Dev. 1: 645-658.